XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Sep. 30, 2021
Dec. 31, 2020
Current Assets    
Cash and cash equivalents $ 10,016 $ 8,050
Accounts receivable (net of allowance for doubtful accounts of $69 in 2021 and $67 in 2020) 8,571 6,803
Inventories (excludes inventories of $2,373 in 2021 and $2,070 in 2020 classified in Other assets - see Note 7) 5,603 5,554
Other current assets 6,868 4,674
Current assets of discontinued operations 0 2,683
Total current assets 31,058 27,764
Investments 435 785
Property, Plant and Equipment, at cost, net of accumulated depreciation of $18,155 in 2021 and $18,162 in 2020 18,565 17,000
Goodwill 18,862 18,882
Other Intangibles, Net 13,384 14,101
Other Assets 11,190 9,881
Noncurrent Assets of Discontinued Operations 0 3,175
Total Assets 93,494 91,588
Current Liabilities    
Loans payable and current portion of long-term debt 3,534 6,431
Trade accounts payable 3,366 4,327
Accrued and other current liabilities 14,214 12,212
Income taxes payable 954 1,597
Dividends payable 1,660 1,674
Current liabilities of discontinued operations 0 1,086
Total current liabilities 23,728 27,327
Long-Term Debt 22,907 25,360
Deferred Income Taxes 1,527 1,005
Other Noncurrent Liabilities 9,469 12,306
Noncurrent Liabilities of Discontinued Operations 0 186
Merck & Co., Inc. Stockholders’ Equity    
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2021 and 2020 1,788 1,788
Other paid-in capital 44,149 39,588
Retained earnings 51,691 47,362
Accumulated other comprehensive loss (4,590) (6,634)
Stockholders' equity before deduction for treasury stock 93,038 82,104
Less treasury stock, at cost: 1,051,780,149 shares in 2021 and 1,046,877,695 shares in 2020 57,244 56,787
Total Merck & Co., Inc. stockholders’ equity 35,794 25,317
Noncontrolling Interests 69 87
Total equity 35,863 25,404
Liabilities and Equity $ 93,494 $ 91,588